Humoral and Cellular Responses to a Delayed Fourth SARS-CoV-2 mRNA-Based Vaccine in Weak Responders to 3 Doses Kidney Transplant Recipients

Humoral and Cellular Responses to a Delayed Fourth SARS-CoV-2 mRNA-Based Vaccine in Weak Responders to 3 Doses Kidney Transplant Recipients

While kidney transplant recipients (KTRs) represent a high-risk population for severe SARS-CoV-2 infection, almost half of them do not develop adequate levels of antibodies conferring clinical protection despite 3 doses of the mRNA vaccine. In the present study we retrospectively analyzed the humora...

Full description

Bibliographic Details
Main Authors: Arnaud Del Bello, Nassim Kamar, Olivier Marion, Jacques Izopet, Florence Abravanel
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Vaccines
Subjects:
solid-organ-transplant recipients
immunodeficiency
kidney transplantation
SARS-CoV-2
vaccine
Online Access:https://www.mdpi.com/2076-393X/10/9/1439

Similar Items

Similar Items